NO301712B1 - Farmasöytisk aktive forbindelser, farmasöytiske midler inneholdende dem og deres anvendelse for fremstilling av farmasöytiske midler - Google Patents
Farmasöytisk aktive forbindelser, farmasöytiske midler inneholdende dem og deres anvendelse for fremstilling av farmasöytiske midlerInfo
- Publication number
- NO301712B1 NO301712B1 NO930559A NO930559A NO301712B1 NO 301712 B1 NO301712 B1 NO 301712B1 NO 930559 A NO930559 A NO 930559A NO 930559 A NO930559 A NO 930559A NO 301712 B1 NO301712 B1 NO 301712B1
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- optionally substituted
- pharmaceutical agents
- hydrogen
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929203497A GB9203497D0 (en) | 1992-02-19 | 1992-02-19 | Pharmaceutical compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO930559D0 NO930559D0 (no) | 1993-02-17 |
| NO930559L NO930559L (no) | 1993-08-20 |
| NO301712B1 true NO301712B1 (no) | 1997-12-01 |
Family
ID=10710655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO930559A NO301712B1 (no) | 1992-02-19 | 1993-02-17 | Farmasöytisk aktive forbindelser, farmasöytiske midler inneholdende dem og deres anvendelse for fremstilling av farmasöytiske midler |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US5378699A (no) |
| EP (1) | EP0557075B1 (no) |
| JP (1) | JPH061784A (no) |
| KR (1) | KR100274103B1 (no) |
| CN (1) | CN1038680C (no) |
| AT (1) | ATE167675T1 (no) |
| AU (1) | AU664412B2 (no) |
| CA (1) | CA2089974A1 (no) |
| CZ (1) | CZ21793A3 (no) |
| DE (1) | DE69319262T2 (no) |
| DK (1) | DK0557075T3 (no) |
| ES (1) | ES2117097T3 (no) |
| FI (1) | FI930719A (no) |
| GB (1) | GB9203497D0 (no) |
| HU (1) | HUT63844A (no) |
| IL (1) | IL104739A (no) |
| MX (1) | MX9300840A (no) |
| MY (1) | MY109777A (no) |
| NO (1) | NO301712B1 (no) |
| NZ (1) | NZ245906A (no) |
| RU (1) | RU2083572C1 (no) |
| TW (1) | TW257760B (no) |
| ZA (1) | ZA931097B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9203497D0 (en) * | 1992-02-19 | 1992-04-08 | Lilly Industries Ltd | Pharmaceutical compounds |
| GB9306062D0 (en) * | 1993-03-24 | 1993-05-12 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5811453A (en) | 1994-12-23 | 1998-09-22 | Alcon Laboratories, Inc. | Viscoelastic compositions and methods of use |
| US5925673A (en) * | 1994-12-23 | 1999-07-20 | Alcon Laboratories, Inc. | Benzofurans and benzopyrans as cytoprotective agents |
| JPH10273467A (ja) * | 1997-01-29 | 1998-10-13 | Snow Brand Milk Prod Co Ltd | 新規テトラロン又はベンゾピラノン誘導体及びその製造方法 |
| FR2796312B1 (fr) * | 1999-07-16 | 2001-09-07 | Atofina | Catalyseur metallique supporte, sa preparation et ses applications dans la fabrication directe du peroxyde d'hydrogene |
| US20040127519A1 (en) * | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors |
| US20040127511A1 (en) * | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| DE102004032418A1 (de) * | 2004-04-07 | 2005-10-27 | Bayer Cropscience Ag | Wirkstoffkombinationen mit insektiziden Eigenschaften |
| US10730885B1 (en) | 2019-04-30 | 2020-08-04 | King Saud University | Coumarin derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4243674A (en) * | 1978-06-12 | 1981-01-06 | Pfizer Inc. | 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore |
| US4931221A (en) * | 1988-12-30 | 1990-06-05 | Ppg Industries, Inc. | Photochromic spiropyran compounds |
| US5284868A (en) * | 1991-10-09 | 1994-02-08 | Eli Lilly And Company | Pharmaceutical compounds |
| GB9203497D0 (en) * | 1992-02-19 | 1992-04-08 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5281619A (en) * | 1992-09-25 | 1994-01-25 | Eli Lilly And Company | Therapy for diabetic complications |
-
1992
- 1992-02-19 GB GB929203497A patent/GB9203497D0/en active Pending
-
1993
- 1993-02-02 TW TW082100682A patent/TW257760B/zh active
- 1993-02-05 US US08/014,016 patent/US5378699A/en not_active Expired - Fee Related
- 1993-02-15 NZ NZ245906A patent/NZ245906A/en unknown
- 1993-02-16 IL IL10473993A patent/IL104739A/xx not_active IP Right Cessation
- 1993-02-17 CZ CZ93217A patent/CZ21793A3/cs unknown
- 1993-02-17 MY MYPI93000265A patent/MY109777A/en unknown
- 1993-02-17 ES ES93301156T patent/ES2117097T3/es not_active Expired - Lifetime
- 1993-02-17 MX MX9300840A patent/MX9300840A/es unknown
- 1993-02-17 DE DE69319262T patent/DE69319262T2/de not_active Expired - Fee Related
- 1993-02-17 DK DK93301156T patent/DK0557075T3/da active
- 1993-02-17 AT AT93301156T patent/ATE167675T1/de not_active IP Right Cessation
- 1993-02-17 KR KR1019930002170A patent/KR100274103B1/ko not_active IP Right Cessation
- 1993-02-17 ZA ZA931097A patent/ZA931097B/xx unknown
- 1993-02-17 AU AU33099/93A patent/AU664412B2/en not_active Ceased
- 1993-02-17 NO NO930559A patent/NO301712B1/no not_active IP Right Cessation
- 1993-02-17 EP EP93301156A patent/EP0557075B1/en not_active Expired - Lifetime
- 1993-02-18 FI FI930719A patent/FI930719A/fi unknown
- 1993-02-18 JP JP5029157A patent/JPH061784A/ja active Pending
- 1993-02-18 HU HU9300446A patent/HUT63844A/hu unknown
- 1993-02-18 CN CN93102342A patent/CN1038680C/zh not_active Expired - Fee Related
- 1993-02-19 CA CA002089974A patent/CA2089974A1/en not_active Abandoned
- 1993-02-19 RU RU9393004522A patent/RU2083572C1/ru active
-
1994
- 1994-08-22 US US08/293,786 patent/US5663375A/en not_active Expired - Fee Related
-
1995
- 1995-06-05 US US08/461,342 patent/US5622987A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2117097T3 (es) | 1998-08-01 |
| KR930017887A (ko) | 1993-09-20 |
| AU664412B2 (en) | 1995-11-16 |
| JPH061784A (ja) | 1994-01-11 |
| CA2089974A1 (en) | 1993-08-20 |
| CN1076696A (zh) | 1993-09-29 |
| TW257760B (no) | 1995-09-21 |
| DK0557075T3 (da) | 1998-12-14 |
| ZA931097B (en) | 1994-08-17 |
| HUT63844A (en) | 1993-10-28 |
| CN1038680C (zh) | 1998-06-10 |
| DE69319262T2 (de) | 1998-11-12 |
| EP0557075A1 (en) | 1993-08-25 |
| FI930719A0 (fi) | 1993-02-18 |
| IL104739A0 (en) | 1993-06-10 |
| HU9300446D0 (en) | 1993-05-28 |
| GB9203497D0 (en) | 1992-04-08 |
| EP0557075B1 (en) | 1998-06-24 |
| FI930719A (fi) | 1993-08-20 |
| NZ245906A (en) | 1995-04-27 |
| RU2083572C1 (ru) | 1997-07-10 |
| DE69319262D1 (de) | 1998-07-30 |
| KR100274103B1 (ko) | 2000-12-15 |
| US5378699A (en) | 1995-01-03 |
| ATE167675T1 (de) | 1998-07-15 |
| AU3309993A (en) | 1993-08-26 |
| MY109777A (en) | 1997-06-30 |
| CZ21793A3 (en) | 1994-02-16 |
| NO930559L (no) | 1993-08-20 |
| NO930559D0 (no) | 1993-02-17 |
| MX9300840A (es) | 1993-09-01 |
| US5622987A (en) | 1997-04-22 |
| US5663375A (en) | 1997-09-02 |
| IL104739A (en) | 1997-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE185792T1 (de) | Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen | |
| DK0539204T3 (da) | Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre | |
| CA2309328A1 (en) | Cyclic amine derivatives and their use as drugs | |
| ES2125294T3 (es) | Imidazo(1,2-a)piridinas como antagonistas de la bradiquinina. | |
| CA2263319A1 (en) | Quinazoline derivatives and pharmaceutical compositions containing them | |
| DK98088A (da) | Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel | |
| BR0214277A (pt) | Solvatos de paclitaxel | |
| DE69812949D1 (de) | Hydroxamsäurederivat und antitumormittel enthaltende pharmazeutische zusammensetzung mit verbesserter antitumor-aktivität und/oder verringerten nebenwirkungen | |
| NO975666D0 (no) | Pyrroldovater og medisinsk sammensetning | |
| NO301712B1 (no) | Farmasöytisk aktive forbindelser, farmasöytiske midler inneholdende dem og deres anvendelse for fremstilling av farmasöytiske midler | |
| PT876388E (pt) | Derivados de eritromicina triciclica | |
| FI921522A (fi) | Pyrazolopyridinfoerening och foerfarande foer dess framstaellning | |
| FI925778A0 (fi) | Farmaceutiskt aktiva bensokinazolinfoereningar | |
| DE69223736D1 (de) | Acridine-1,8-Dionderivate als therapeutisches Mittel | |
| FI913034A0 (fi) | Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning. | |
| YU82693A (sh) | Farmaceutske formulacije disulfonil metana i novi disulfonil metani | |
| ITMI913461A1 (it) | Composizioni terapeutiche adatte per la somministrazione rettale contenenti come principio attivo uno o piu' tioesteri del glutatione | |
| DE69111530D1 (de) | Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
| ES2102512T3 (es) | Inhibidor de la hipertrofia de vasos sanguineos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN AUGUST 2002 |